ERBB2 and non-small cell lung carcinoma: During the last years several oncogenic mutations and genetic rearrangements have been discovered in NSCLC, with EGFR, KRAS, ALK, MET, BRAF, PIK3CA, ROS1, HER2 and RET being the most abundant alterations in NSCLC adenocarcinoma [4].